Tianeptine, originally developed as a therapeutic medication in the 1980s, has generated considerable debate globally . Unlike most antidepressants which work by boosting serotonin levels, tianeptine seems to promote mood reuptake and affects glutamate , causing atypical effects . Its presence on the copyright, often without medical oversight , has